---
category: news
title: "Understanding the AI-enabled drug discovery landscape"
excerpt: "AI-enabled drug discovery companies (AIDDs) have taken the  bioscience world by storm, raising more than $5.2 billion from  investors in 2021, while 15 AI-enabled candidate drugs are in  clinical trials,"
publishedDateTime: 2022-07-08T17:27:00Z
originalUrl: "https://www.thepharmaletter.com/article/understanding-the-ai-enabled-drug-discovery-landscape"
webUrl: "https://www.thepharmaletter.com/article/understanding-the-ai-enabled-drug-discovery-landscape"
type: article
quality: 17
heat: 17
published: false

provider:
  name: The Pharma Letter
  domain: thepharmaletter.com

topics:
  - AI

secured: "G72FQ7A4zTTYTJ1yQ46/PRYtbtzV3aRLB50OksS/oWvzlCrK5DwbTolIZFTU0C0pVB8pizu5iohTavixmpNFd80HC4BaL0H2wpx5z5mMk2DagVRIt6qBXE54fTQqFb2Pt9Pkh6Ai0OjgQdMfVKmr/lVQsO8hI/LkUfJifDylQVHLssbtUpOdqk3XSrnueQSOJ7t6yCru1y2b0seoJ7I9yk4jWeKw5WOIzsm9Ds9LDVOHSBpTBPhV40tNi9Dz3boyzvsLogLgvj1ndRjUfl1IkDUCiUc7L0UnozxVe3OlFEM2Y9eLShxGEf/yGwoeLAJkGElrJLxbn/Tr9TLOsAk2pKGAxFiUnFY4Q51CUWDpX0Q=;XU0J5uUK2ELjbSRDGa3hIg=="
---

